OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SARS-CoV-2: Immunity, Challenges with Current Vaccines, and a Novel Perspective on Mucosal Vaccines
Raju Sunagar, Amit Kumar Singh, Sudeep Kumar
Vaccines (2023) Vol. 11, Iss. 4, pp. 849-849
Open Access | Times Cited: 23
Raju Sunagar, Amit Kumar Singh, Sudeep Kumar
Vaccines (2023) Vol. 11, Iss. 4, pp. 849-849
Open Access | Times Cited: 23
Showing 23 citing articles:
Cross-protection induced by highly conserved human B, CD4+, and CD8+ T-cell epitopes-based vaccine against severe infection, disease, and death caused by multiple SARS-CoV-2 variants of concern
Swayam Prakash, Nisha R. Dhanushkodi, Latifa Zayou, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 15
Swayam Prakash, Nisha R. Dhanushkodi, Latifa Zayou, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 15
Plaque Psoriasis Exacerbation and COVID-19 Vaccination: Assessing the Characteristics of the Flare and the Exposome Parameters
Emmanouil Karampinis, Myrto-Maria Papadopoulou, Kleoniki Chaidaki, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 178-178
Open Access | Times Cited: 12
Emmanouil Karampinis, Myrto-Maria Papadopoulou, Kleoniki Chaidaki, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 178-178
Open Access | Times Cited: 12
SARS-CoV-2 Vaccines: The Advantage of Mucosal Vaccine Delivery and Local Immunity
Joshua Tobias, Peter Steinberger, Joy Wilkinson, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 795-795
Open Access | Times Cited: 5
Joshua Tobias, Peter Steinberger, Joy Wilkinson, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 795-795
Open Access | Times Cited: 5
Biomimetic Molecularly Imprinted Nanogels for the Recognition of Spike Glycoproteins
Iulia Elena Neblea, Tanța-Verona Iordache, Andrei Sârbu, et al.
ACS Applied Bio Materials (2025)
Closed Access
Iulia Elena Neblea, Tanța-Verona Iordache, Andrei Sârbu, et al.
ACS Applied Bio Materials (2025)
Closed Access
The comprehensive insights into the B-cells-mediated immune response against COVID-19 infection amid the ongoing evolution of SARS-CoV-2
Manish Dhawan, Nanamika Thakur, Manish Sharma, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 185, pp. 117936-117936
Closed Access
Manish Dhawan, Nanamika Thakur, Manish Sharma, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 185, pp. 117936-117936
Closed Access
Dynamic Evolution of Humoral and T-Cell Specific Immune Response to COVID-19 mRNA Vaccine in Patients with Multiple Sclerosis Followed until the Booster Dose
Serena Ruggieri, Alessandra Aiello, Carla Tortorella, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8525-8525
Open Access | Times Cited: 10
Serena Ruggieri, Alessandra Aiello, Carla Tortorella, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8525-8525
Open Access | Times Cited: 10
A multi-epitope/CXCL11 prime/pull coronavirus mucosal vaccine boosts the frequency and the function of lung-resident memory CD4 + and CD8 + T cells and enhanced protection against COVID-19-like symptoms and death caused by SARS-CoV-2 infection
Latifa Zayou, Swayam Prakash, Nisha R. Dhanushkodi, et al.
Journal of Virology (2023) Vol. 97, Iss. 12
Open Access | Times Cited: 8
Latifa Zayou, Swayam Prakash, Nisha R. Dhanushkodi, et al.
Journal of Virology (2023) Vol. 97, Iss. 12
Open Access | Times Cited: 8
Immune Response to an Inactivated Vaccine of SARS-CoV-2 (CoronaVac) in an Indigenous Brazilian Population: A Cohort Study
Laís Albuquerque de Oliveira, Isa Rita Brito de Morais, Marcelo dos Santos Barbosa, et al.
Vaccines (2024) Vol. 12, Iss. 4, pp. 402-402
Open Access | Times Cited: 1
Laís Albuquerque de Oliveira, Isa Rita Brito de Morais, Marcelo dos Santos Barbosa, et al.
Vaccines (2024) Vol. 12, Iss. 4, pp. 402-402
Open Access | Times Cited: 1
Sex-biased immunogenicity of a mucosal subunit vaccine against SARS-CoV-2 in mice
Jianping Li, Kevin Hsu, Savannah E. Howe, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Jianping Li, Kevin Hsu, Savannah E. Howe, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Cross-Protection Induced by Highly Conserved Human B, CD4+,and CD8+T Cell Epitopes-Based Coronavirus Vaccine Against Severe Infection, Disease, and Death Caused by Multiple SARS-CoV-2 Variants of Concern
Swayam Prakash, Nisha R. Dhanushkodi, Latifa Zayou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Swayam Prakash, Nisha R. Dhanushkodi, Latifa Zayou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Updated Considerations for the Immunopharmacological Aspects of the “Talented mRNA Vaccines”
Cristiana Perrotta, Claudio Fenizia, Carla Carnovale, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1481-1481
Open Access | Times Cited: 4
Cristiana Perrotta, Claudio Fenizia, Carla Carnovale, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1481-1481
Open Access | Times Cited: 4
Immunogenicity and Tolerability of a SARS-CoV-2 TNX-1800, a Live Recombinant Poxvirus Vaccine Candidate, in Syrian Hamsters and New Zealand White Rabbits
Mayanka Awasthi, Anthony Macaluso, Scott J. Goebel, et al.
Viruses (2023) Vol. 15, Iss. 10, pp. 2131-2131
Open Access | Times Cited: 3
Mayanka Awasthi, Anthony Macaluso, Scott J. Goebel, et al.
Viruses (2023) Vol. 15, Iss. 10, pp. 2131-2131
Open Access | Times Cited: 3
Delving into revolutionary SARS-CoV-2 vaccine approaches: Molecular and virological examinations; principles of SARS-CoV-2 vaccine platform
Fahime Edalat, Fatemeh Hosseini, Afagh Moattari, et al.
Vacunas (2023) Vol. 25, Iss. 1, pp. 109-127
Closed Access | Times Cited: 3
Fahime Edalat, Fatemeh Hosseini, Afagh Moattari, et al.
Vacunas (2023) Vol. 25, Iss. 1, pp. 109-127
Closed Access | Times Cited: 3
Immunogenicity and tolerability of a SARS-CoV-2 TNX-1800, a live recombinant poxvirus vaccine candidate, in Syrian Hamsters and New Zealand White Rabbits
Mayanka Awasthi, Anthony Macaluso, Scott J Goebel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Mayanka Awasthi, Anthony Macaluso, Scott J Goebel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Ameliorative role of diets fortified with Artocarpus altilis in a Drosophila melanogaster model of aluminum chloride-induced neurotoxicity
Jamiyu A. Saliu, Ayobami Matthew Olajuyin, Samuel Faith Olowolayemo
Clinical Phytoscience (2024) Vol. 10, Iss. 1
Open Access
Jamiyu A. Saliu, Ayobami Matthew Olajuyin, Samuel Faith Olowolayemo
Clinical Phytoscience (2024) Vol. 10, Iss. 1
Open Access
Delving into revolutionary SARS-CoV-2 vaccine approaches: Molecular and virological examinations; principles of SARS-CoV-2 vaccine platform
Fahime Edalat, Fatemeh Hosseini, Afagh Moattari, et al.
Vacunas (English Edition) (2024) Vol. 25, Iss. 1, pp. 109-127
Closed Access
Fahime Edalat, Fatemeh Hosseini, Afagh Moattari, et al.
Vacunas (English Edition) (2024) Vol. 25, Iss. 1, pp. 109-127
Closed Access
COVID-19 Vaccination Strategies in the Endemic Period: Lessons from Influenza
Eliel Nham, Ji Yun Noh, Ok Hyun Park, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 514-514
Open Access
Eliel Nham, Ji Yun Noh, Ok Hyun Park, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 514-514
Open Access
An intranasal attenuated Coxsackievirus B3 vaccine induces strong systemic and mucosal immunity against CVB3 lethal challenge
Huixiong Deng, Yanlei Li, Xuanting He, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 8
Open Access
Huixiong Deng, Yanlei Li, Xuanting He, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 8
Open Access
Mucosal immunity in COVID-19: a comprehensive review
Saeed Awad M. Alqahtani
Frontiers in Immunology (2024) Vol. 15
Open Access
Saeed Awad M. Alqahtani
Frontiers in Immunology (2024) Vol. 15
Open Access
T Cell Peptide Prediction, Immune Response, and Host–Pathogen Relationship in Vaccinated and Recovered from Mild COVID-19 Subjects
Iole Macchia, Valentina La Sorsa, Alessandra Ciervo, et al.
Biomolecules (2024) Vol. 14, Iss. 10, pp. 1217-1217
Open Access
Iole Macchia, Valentina La Sorsa, Alessandra Ciervo, et al.
Biomolecules (2024) Vol. 14, Iss. 10, pp. 1217-1217
Open Access
Safety and Immunogenicity of the Live Attenuated Vaccine QazCOVID-Live Against Coronavirus Infection COVID-19: Pre-Clinical Study Results
Lespek Kutumbetov, Balzhan Myrzakhmetova, Aiganym A. Tussipova, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1401-1401
Open Access
Lespek Kutumbetov, Balzhan Myrzakhmetova, Aiganym A. Tussipova, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1401-1401
Open Access
A Multi-Epitope/CXCL11 Prime/Pull Coronavirus Mucosal Vaccine Boosts the Frequency and the Function of Lung-Resident CD4+and CD8+Memory T Cells and Protects Against COVID-19-like Symptoms and Death Caused by SARS-CoV-2 infection
Latifa Zayou, Swayam Prakash, Nisha R. Dhanushkodi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Latifa Zayou, Swayam Prakash, Nisha R. Dhanushkodi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Methodical and Immunological Insights of Prime COVID-19 Vaccines
Wilson Pearl Evangeline, Sakthivelnathan Divyasri, C.V. Akshaya, et al.
Coronaviruses (2023) Vol. 5, Iss. 3
Closed Access
Wilson Pearl Evangeline, Sakthivelnathan Divyasri, C.V. Akshaya, et al.
Coronaviruses (2023) Vol. 5, Iss. 3
Closed Access
